Accession Number: | 0001209191-21-051657 |
Date: | 2021-08-13 |
Issuer: | ORIC PHARMACEUTICALS, INC. (ORIC) |
Original Submission Date: |
HOERTER STEVEN L.
C/O ORIC PHARMACEUTICALS, INC.
240 E. GRAND AVE., 2ND FLOOR
SOUTH SAN FRANCISCO, CA 94080
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 18.63 | 2021-08-13 | deemed execution date | A | 33,250 (a) | 2031-08-12 | common stock 33,250 | $18.63 | 33,250 | direct |
ID | footnote |
---|---|
f1 | one thirty-sixth (1/36th) of the shares subject to the option shall vest on each monthly anniversary of august 13, 2021. |